Study of colorectal cancer screening in adults 40+
Part of Cancer, Digestive system clinical trials.
This study follows people age 40 and older to see how well colorectal cancer screening works in everyday community care. You may answer risk and follow-up questions over time, and the study looks for any cancer diagnoses that happen outside the study hospitals.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 40 years old
- Be able to make your own decisions and take part in the study
- Agree to complete a colorectal cancer risk questionnaire and yearly follow-up interviews
- Be willing to let the study team know about cancer diagnosis updates from other hospitals
- Have no history of colorectal cancer or other cancers
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new tool to help predict a person's risk of colorectal cancer. If you are already scheduled for a colonoscopy, your data could help improve this risk model for others.
This study looks at patterns of colorectal (colon and rectum) findings in people who are having a colonoscopy as part of routine care. It may help improve how doctors detect and understand colorectal cancer and related growths over time.
This trial is testing a new way to screen for colorectal cancer in adults aged 45 to 74. If you join, you will help researchers find better methods for early detection.
This study enrolls people newly diagnosed with colon or rectal cancer to learn about their care and outcomes. You might be able to join if you meet the age, language, and consent requirements.
This study is collecting information from people with newly diagnosed colon or rectal cancer, to better understand the disease and support future research. It may help you and others by improving how colorectal cancer is studied and potentially treated over time.
This study recruits adults in Yangzhou to help screen for colorectal cancer risk using a lab test based on “methylation,” a way cells can carry disease-related changes. You would mainly complete a risk questionnaire and phone follow-ups, and agree to share any cancer diagnosis information during the study.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.